Autoinflammatory diseases are a group of rare, primarily monogenic disorders characterized by recurrent episodes of systemic inflammation in the absence of high-titer autoantibodies or antigen-specific T cells.
These conditions result from dysregulation of the innate immune system, often due to mutations in genes involved in the inflammatory response. Common symptoms include recurrent fever, rash, joint pain, and abdominal discomfort. Conditions such as Familial Mediterranean Fever, Cryopyrin-Associated Periodic Syndromes, and TNF Receptor-Associated Periodic Syndrome fall under this category. Diagnosis is typically based on clinical presentation, genetic testing, and exclusion of other inflammatory conditions. Treatment varies based on the underlying condition and may include nonsteroidal anti-inflammatory drugs, colchicine, corticosteroids, and biologics targeting specific inflammatory pathways. In rare cases, hematopoietic stem cell transplantation may be necessary to cure the disease. Given their complexity and rarity, these diseases often require specialized care and ongoing monitoring.
Il 10 aprile 2026 si è tenuto il simposio SwissRITA presso l'Ospedale pediatrico universitario di Zurigo, organizzato da SwissRITA e dalla Rete infermieristica di immunologia.
Le 10 avril 2026, le symposium SwissRITA s'est tenu à l'hôpital universitaire pédiatrique de Zurich, organisé par SwissRITA et le réseau de soins infirmiers en immunologie.
Am 10. April 2026 fand das SwissRITA Symposium am Universitäts-Kinderspital Zürich statt, organisiert von SwissRITA und dem Pflegenetzwerk Immunologie.
On 10 April 2026, the SwissRITA Symposium took place at the University Children’s Hospital Zurich, organised by SwissRITA and the Immunology Nursing Network.